Blair William & CO Pfizer Inc Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Pfizer Inc stock. As of the latest transaction made, Blair William & CO holds 1,953,310 shares of PFE stock, worth $53.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

1,953,310

Previous 1,050,934 85.86%

Holding current value

$53.6 Million

Previous $29.2 Million 87.41%

% of portfolio

0.17%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $22.8 Million - $26.7 Million	902,376 Added 85.86%	1,953,310 $54.7 Million
Q1 2024 May 09, 2024	SELL	$25.89 - $29.73 $691,366 - $793,909	-26,704 Reduced 2.48%	1,050,934 $29.2 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $1.81 Million - $2.35 Million	-69,307 Reduced 6.04%	1,077,638 $31 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $2.24 Million - $2.62 Million	-69,775 Reduced 5.73%	1,146,945 $38 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $3.2 Million - $3.7 Million	-88,497 Reduced 6.78%	1,216,720 $44.6 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $1.13 Million - $1.47 Million	-28,757 Reduced 2.16%	1,305,217 $53.3 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $3.16 Million - $4.12 Million	75,619 Added 6.01%	1,333,974 $68.4 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $1.78 Million - $2.18 Million	40,736 Added 3.35%	1,258,355 $55.1 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $272,944 - $323,627	-5,866 Reduced 0.48%	1,217,619 $63.8 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $704,184 - $872,572	15,392 Added 1.27%	1,223,485 $63.3 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $2.66 Million - $3.94 Million	64,298 Added 5.62%	1,208,093 $71.3 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $2.19 Million - $2.82 Million	55,915 Added 5.14%	1,143,795 $49.2 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $2.36 Million - $2.67 Million	-65,603 Reduced 5.69%	1,087,880 $42.6 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $939,829 - $1.06 Million	-28,063 Reduced 2.38%	1,153,483 $41.8 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $2.57 Million - $3.26 Million	76,683 Added 6.94%	1,181,546 $43.5 Million
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $6.09 Million - $7.14 Million	191,696 Added 20.99%	1,104,863 $40.5 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $1.37 Million - $1.66 Million	45,418 Added 5.23%	913,167 $29.9 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $277,598 - $396,627	10,270 Added 1.2%	867,749 $28.3 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $1.59 Million - $1.81 Million	-48,403 Reduced 5.34%	857,479 $33.6 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $907,640 - $1.18 Million	-27,936 Reduced 2.99%	905,882 $32.5 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $260,080 - $292,010	7,033 Added 0.76%	933,818 $40.5 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $349,612 - $384,107	-9,323 Reduced 1.0%	926,785 $39.4 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $328,495 - $374,520	8,539 Added 0.92%	936,108 $40.9 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $231,845 - $281,214	6,726 Added 0.73%	927,569 $40.9 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $286,068 - $304,977	8,674 Added 0.95%	920,843 $33.4 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $1.62 Million - $1.88 Million	-50,757 Reduced 5.27%	912,169 $32.4 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $397,124 - $421,362	11,940 Added 1.26%	962,926 $34.9 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $29.5 Million - $32.5 Million	950,986	950,986 $34 Million

Others Institutions Holding PFE

# of Institutions

3,245

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account